Article Text
Abstract
Pubertal induction in girls with ovarian insufficiency aims to mimic normal puberty, a highly complex process. Here we amalgamate the sparse global evidence and propose three options for pubertal induction regimens including oral ethinyloestradiol, and oral and transdermal 17β-oestradiol. The introduction of progestogens is discussed and the transition to hormone supplementation for adult women. The merits and disadvantages of the different options are detailed. The available evidence indicates that transdermal 17β-oestradiol has the most favourable efficacy, safety and cost profile but randomised controlled trials are urgently required to determine which regimen provides the best clinical outcomes.
- Puberty
- Oestrogen
- Progestogen
Statistics from Altmetric.com
Footnotes
Contributors Literature search, preparation of manuscript and revisions of manuscript: DM; Revising manuscript content: WH, LB, AS,AM, MS; Liaising with other experts and reviewers WH, MS.
Competing interests None declared.
Provenance and peer review Commissioned; externally peer reviewed